R&D | April 12, 2026
Touchlight and SVF partner to advance next-gen Hepatitis B/D vaccine development
The company says the platform offers improved manufacturability and functional advantages
The company says the platform offers improved manufacturability and functional advantages
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The event also featured discussions on emerging trends in joint replacement surgery
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
The nationwide campaign, running from April 9–23 highlights the first 1,000 days, nutrition, responsive caregiving and play-based learning as critical pillars for children
Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change
Subscribe To Our Newsletter & Stay Updated
